IPSEN BIOINNOVATION LIMITED
Company number 05480340 · Monitor this company
Free AI analysis
Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.
Overview
- Company type
- Private Limited Company
- Incorporated
- 2005-06-14
- Registered office
- 5th Floor The Point, 37 North Wharf Road, London, United Kingdom, W2 1AF
- Postcode
- W2 1AF
- Capital
- 40,008,187 GBP
- Accounts category
- Full
Accounts
- Last made up to
- 2024-12-31
- Next due by
- 2026-09-30
- Financial year end
- 31 December
Confirmation statement
- Last statement dated
- 2025-10-03
- Next due by
- 2026-10-17
Nature of business (SIC)
- 72110 Research and experimental development on biotechnology
Officers 7 current · 33 resigned
Lynne Elizabeth Duncan MILLAR-KELLY
Secretary
Lynne Elizabeth Duncan MILLAR-KELLY
Director
Alexandre VISCIGLIO
Director
CATHERINE LAMB
Director
CATHERINE LAMB
Secretary
Group structure
Controlled by IPSEN DEVELOPMENTS LIMITED — since 2016-04-06
From persons-with-significant-control filings on the public register.
Contact details
- Website
- http://www.syntaxin.com
Previous company names
| Name | Date changed |
|---|---|
| SYNTAXIN LIMITED | 2015-03-06 |
Previous registered addresses 2
| Address | Changed on |
|---|---|
| UNITS 4-10 THE QUADRANT, BARTON, LANE, ABINGDON, OXFORDSHIRE, OX14 3YS | 2016-08-25 |
| PORTON DOWN, SALISBURY, WILTSHIRE, SP4 0JD | 2007-09-17 |
Among its peers
Among the oldest 25%
of 226 similar companies in W, trading since 2005
The class of 2005
34%
of the 154,486 companies incorporated in 2005 are still active today; 63% have since been dissolved.
A fact about the year, not a forecast for this company.